Is Altria Stock Worth Holding as Pricing Offsets Volume Pressure?

Altria Group, Inc. MO is leaning on pricing, margins and shareholder returns to keep earnings resilient as U.S. cigarette demand declines. Second-quarter results showed that the smokeable business can still convert pricing into profit growth despite lower volumes.

The question is whether that resilience is enough. Trade-down pressure, uneven smoke-free results and a valuation above MO’s five-year median keep the case balanced rather than decisively bullish.

Altria Group, Inc. Price, Consensus and EPS Surprise

Altria Group, Inc. price-consensus-eps-surprise-chart | Altria Group, Inc. Quote

Altria’s Pricing Keeps Earnings Resilient

Second-quarter smokeable revenues net of excise taxes rose 2%, while adjusted operating companies income increased 2.4% to $3.02 billion. The adjusted operating companies income margin expanded 30 basis points to 64.8%.

Smokeable price realization was 4.5%, led by Marlboro pricing and partly offset by Basic mix. Pricing helped counter lower shipment volume, promotional spending and higher costs, supporting Altria’s narrowed 2026 adjusted earnings guidance of $5.61-$5.72 per share.

MO’s Discount Mix Tests the Pricing Thesis

Domestic cigarette shipments fell 3.2% in the second quarter and an estimated 4.5% after adjusting for trade inventory movements. Industry discount retail share reached 33.8%, up 2.6 percentage points year over year.

Altria’s discount cigarette shipments jumped 67.3%. Basic helps the company compete for value-sensitive smokers, but a larger discount mix partly offsets premium pricing and leaves the earnings model exposed to continued cigarette category contraction.

Altria’s Smoke-Free Push Offers Mixed Signals

Nicotine pouches represented 59.9% of the oral tobacco category, while on!’s retail share of the overall oral market improved to 8.6%. on! PLUS expanded to about 120,000 stores, and first-half on! shipments increased 5.1%.

Still, Oral Tobacco Products revenues fell 5.3% and adjusted operating companies income declined 8%. on!’s nicotine pouch category share fell 1.7 percentage points to 14.4%, showing that category growth does not guarantee share gains.

Philip Morris International Inc. PM provides a competitive reference point. Its smoke-free business generated 42% of total net revenues in first-half 2026, led by IQOS and ZYN.

British American Tobacco p.l.c. BTI is another relevant peer. Its first-half 2026 New Categories revenues rose 18%, led by Modern Oral and U.S. vapor.

MO’s Valuation Sits Below Benchmarks but Above Its Median

MO trades at 11.6X forward 12-month earnings, below the Zacks sub-industry’s 15.4X, the Zacks Consumer Staples sector’s 17.2X and the S&P 500’s 20.3X.

That discount is not absolute. Altria’s five-year median multiple is 9.7X, so the stock is priced above its own typical valuation even while screening cheaper than broader benchmarks.

Image Source: Zacks Investment Research

Altria’s Cash Returns Strengthen the Hold Case

Altria paid about $3.6 billion in dividends and repurchased $335 million of shares in the first half of 2026. The company also had $665 million remaining under its repurchase authorization at June 30.

The dividend yield is 6.33%, the payout ratio is 76% and debt to EBITDA stands at 1.9 times. Those metrics support the income case, although they do not remove risks tied to falling cigarette volumes, mix pressure and tobacco regulation.

MO’s Mixed Scores Reinforce a Cautious Stance

Pricing power, cash returns and below-benchmark valuation support a measured hold case, but the premium to Altria’s historical median and structural volume pressure limit the argument for aggressive buying.

MO currently carries a Zacks Rank #3 (Hold), with a VGM Score of C, Value Score of C, Growth Score of C and Momentum Score of D. A Zacks Rank #3 can support holding an existing position, while the C scores are middling and the D Momentum Score is less favorable for near-term trading. Stronger buying setups generally pair a Zacks Rank #1 (Strong Buy) or 2 (Buy) with A or B Style Scores. You can see the complete list of today’s Zacks #1 Rank stocks here.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research